RemeGen
(OTC) REGMF
RemeGen Financials at a Glance
Market Cap
$6.11B
Revenue (TTM)
$3.22B
Net Income (TTM)
$690.18M
EPS (TTM)
$0.18
P/E Ratio
61.41
Dividend
$0.00
Beta (Volatility)
0.05 (Low)
Dividend
$0.00
Beta (Volatility)
0.05 (Low)
Price
$10.95
Volume
500
Open
$10.95
Price
$10.95
Volume
500
Open
$10.95
Previous Close
$10.95
Daily Range
$10.95 - $10.95
52-Week Range
$1.50 - $15.91
Dividend
$0.00
Beta (Volatility)
0.05 (Low)
Price
$10.95
Volume
500
Open
$10.95
Previous Close
$10.95
Daily Range
$10.95 - $10.95
52-Week Range
$1.50 - $15.91
REGMF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout RemeGen
Industry
Biotechnology
Sector
Health CareEmployees
3,048
CEO
Jian Min Fang, PhD
Website
www.remegen.comHeadquarters
Yantai, CN
REGMF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
22%
Net Income Margin
22%
Return on Equity
26%
Return on Capital
16%
Return on Assets
10%
Earnings Yield
1.63%
Dividend Yield
0.00%
Payout Ratio
5.91%
Stock Overview
Market Cap
$6.11B
Shares Outstanding
558.40M
Volume
500
Short Interest
0.00%
Avg. Volume
49.492
Financials (TTM)
Gross Profit
$2.55B
Operating Income
$126.84M
EBITDA
$438.91M
Operating Cash Flow
$54.75M
Capital Expenditure
$194.84M
Free Cash Flow
$140.09M
Cash & ST Invst.
$2.42B
Total Debt
$2.20B
RemeGen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.51B
+197.0%
Gross Profit
$1.32B
+224.5%
Gross Margin
87.31%
N/A
Market Cap
$6.11B
N/A
Market Cap/Employee
$2.04M
N/A
Employees
2,999
N/A
Net Income
$1.24B
+412.6%
EBITDA
$1.24B
+477.4%
Quarterly Fundamentals
Net Cash
$220.83M
+111.6%
Accounts Receivable
$806.55M
+29.4%
Inventory
$661.82M
+0.4%
Long Term Debt
$752.28M
-39.2%
Short Term Debt
$1.45B
+1.3%
Return on Assets
9.78%
N/A
Return on Invested Capital
16.17%
N/A
Free Cash Flow
$184.34M
+49.4%
Operating Cash Flow
$159.25M
+43.0%